BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29727799)

  • 1. When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.
    Stensjøen AL; Berntsen EM; Jakola AS; Solheim O
    Clin Neurol Neurosurg; 2018 Jul; 170():38-42. PubMed ID: 29727799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which Parameter Is More Important for the Prognosis of New-Onset Adult Glioblastoma: Residual Tumor Volume or Extent of Resection?
    Xing Y; Wang X
    World Neurosurg; 2018 Aug; 116():e444-e451. PubMed ID: 29753893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There an Indication for Intraoperative MRI in Subtotal Resection of Glioblastoma? A Multicenter Retrospective Comparative Analysis.
    Coburger J; Segovia von Riehm J; Ganslandt O; Wirtz CR; Renovanz M
    World Neurosurg; 2018 Feb; 110():e389-e397. PubMed ID: 29138078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
    Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
    J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
    Rahman M; Abbatematteo J; De Leo EK; Kubilis PS; Vaziri S; Bova F; Sayour E; Mitchell D; Quinones-Hinojosa A
    J Neurosurg; 2017 Jul; 127(1):123-131. PubMed ID: 27689459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
    Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
    J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
    Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
    J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.
    Amelot A; Deroulers C; Badoual M; Polivka M; Adle-Biassette H; Houdart E; Carpentier AF; Froelich S; Mandonnet E
    Neurosurgery; 2017 May; 80(5):793-799. PubMed ID: 28387870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
    Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
    Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.
    Ringel F; Pape H; Sabel M; Krex D; Bock HC; Misch M; Weyerbrock A; Westermaier T; Senft C; Schucht P; Meyer B; Simon M;
    Neuro Oncol; 2016 Jan; 18(1):96-104. PubMed ID: 26243790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of reproducibility in MRI quantitative volumetric assessment and its role in the prediction of overall survival and progression-free survival in glioblastoma.
    Blomstergren A; Rydelius A; Abul-Kasim K; Lätt J; Sundgren PC; Bengzon J
    Acta Radiol; 2019 Apr; 60(4):516-525. PubMed ID: 29966430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma.
    Meier R; Porz N; Knecht U; Loosli T; Schucht P; Beck J; Slotboom J; Wiest R; Reyes M
    J Neurosurg; 2017 Oct; 127(4):798-806. PubMed ID: 28059651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.
    Sonabend AM; Zacharia BE; Cloney MB; Sonabend A; Showers C; Ebiana V; Nazarian M; Swanson KR; Baldock A; Brem H; Bruce JN; Butler W; Cahill DP; Carter B; Orringer DA; Roberts DW; Sagher O; Sanai N; Schwartz TH; Silbergeld DL; Sisti MB; Thompson RC; Waziri AE; Ghogawala Z; McKhann G
    Neurosurgery; 2017 Apr; 80(4):590-601. PubMed ID: 27509070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.